1979
DOI: 10.3109/00365527909179894
|View full text |Cite
|
Sign up to set email alerts
|

Lymph and Blood Enzymes and Pathologic Alterations in Canine Experimental Pancreatitis after Administration of Benzo-Pyrones

Abstract: The effect of Venalot, a combination of two benzo-pyrones, on canine experimental acute pancreatitis was examined. Activities of lymph and blood plasma enzymes, thoracic duct lymph flow, and morphological changes of the pancreas were compared with those of a control group of dogs. The drug was found to enhance the removal of amylase and trypsin via lymph from the gland and to decrease the elevation of plasma amylase and lactate dehydrogenase. When administered simultaneously with the induction of pancreatitis,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1983
1983
2003
2003

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 10 publications
0
3
0
Order By: Relevance
“…Immuno‐nanogold electron microscopy showed that T1α/podoplanin is predominantly localized to the apical, luminal plasma membrane of intestinal lymphatic endothelial cells. This localization is similar to that reported for other cell types (Dobbs et al ., 1988; Rishi et al ., 1995; Williams et al ., 1996; Breiteneder‐Geleff et al ., 1997; Zimmer et al ., 1997) and is compatible with a protective function towards the proteinase‐containing lymph (Bartos et al ., 1979). It is of interest that T1α/podoplanin is also expressed by alveolar epithelial cells, cells of the choroid plexus, ependymal epithelia and mesothelia that are also exposed to an external or internal fluid compartment.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Immuno‐nanogold electron microscopy showed that T1α/podoplanin is predominantly localized to the apical, luminal plasma membrane of intestinal lymphatic endothelial cells. This localization is similar to that reported for other cell types (Dobbs et al ., 1988; Rishi et al ., 1995; Williams et al ., 1996; Breiteneder‐Geleff et al ., 1997; Zimmer et al ., 1997) and is compatible with a protective function towards the proteinase‐containing lymph (Bartos et al ., 1979). It is of interest that T1α/podoplanin is also expressed by alveolar epithelial cells, cells of the choroid plexus, ependymal epithelia and mesothelia that are also exposed to an external or internal fluid compartment.…”
Section: Discussionmentioning
confidence: 99%
“…In vivo expression of T1a/ podoplanin in lymphatic endothelium was ®rst reported by Wetterwald et al (1996), who named it `E11 antigen'. It was characterized further under the name `podoplanin', because of its low level expression in kidney podocytes (Breiteneder-Geleff et al, 1997). Podoplanin is homologous to T1a, which was originally found to encode an antigen that is selectively expressed at the apical surface of alveolar type I cells in rat lung (Dobbs et al, 1988;Rishi et al, 1995).…”
Section: Introductionmentioning
confidence: 99%
“…Like the experimental data of Schiller et al [24], Konstantinov and Jantschulev [11] and Bartos et al [2], clinical reports on tho racic duct drainage have been conflicting in contrast to the results of Brzek and Bartos [3] and Pikovsky and Alexeev [19]. Harlan Stone et al [7] had to terminate a clinical trial of thoracic duct drainage because of an unacceptable high rate of mortality.…”
Section: Discussionmentioning
confidence: 48%